Lates News

Every AI Express, Pacific Securities released a research report on August 29 giving a buy rating to Rongtai Health (603579.SH). The rating reasons mainly include: 1) Online sales in the first half of 2025 increased by 30% year-on-year, with outstanding performance in overseas emerging markets and cross-border e-commerce; 2) Gross profit margin in the second quarter of 2025 increased, with increased investment in research and development and improved operational efficiency; 3) Multiple layouts of new intelligent health businesses, and technology accelerating empowerment. (Daily Economic News)